127 related articles for article (PubMed ID: 1899413)
1. Radiosensitizing and cytotoxic properties of mitomycin C in a C3H mouse mammary carcinoma in vivo.
Grau C; Overgaard J
Int J Radiat Oncol Biol Phys; 1991 Feb; 20(2):265-9. PubMed ID: 1899413
[TBL] [Abstract][Full Text] [Related]
2. Trimodality therapy (drug/hyperthermia/radiation) with BCNU or mitomycin C.
Herman TS; Teicher BA; Holden SA
Int J Radiat Oncol Biol Phys; 1990 Feb; 18(2):375-82. PubMed ID: 2105922
[TBL] [Abstract][Full Text] [Related]
3. Thermochemotherapy in vivo of a C3H mouse mammary carcinoma: single fraction heat and drug treatment.
Monge OR; Rofstad EK; Kaalhus O
Eur J Cancer Clin Oncol; 1988 Oct; 24(10):1661-9. PubMed ID: 3145205
[TBL] [Abstract][Full Text] [Related]
4. Thermochemotherapy in vivo of a C3H mouse mammary carcinoma: thermotolerant tumours.
Monge OR; Rofstad EK
Int J Hyperthermia; 1989; 5(5):579-87. PubMed ID: 2504842
[TBL] [Abstract][Full Text] [Related]
5. Interaction of hyperthermia and cis-diamminedichloroplatinum(II) alone or combined with radiation in a C3H mammary carcinoma in vivo.
Overgaard J; Radacic MM; Grau C
Cancer Res; 1991 Jan; 51(2):707-11. PubMed ID: 1985787
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of radiation-induced regrowth delay in murine tumors by fludarabine.
Grégoire V; Hunter N; Milas L; Brock WA; Plunkett W; Hittelman WN
Cancer Res; 1994 Jan; 54(2):468-74. PubMed ID: 8275483
[TBL] [Abstract][Full Text] [Related]
7. Effect of cancer chemotherapy on the hypoxic fraction of a solid tumor measured using a local tumor control assay.
Grau C; Overgaard J
Radiother Oncol; 1988 Dec; 13(4):301-9. PubMed ID: 2464183
[TBL] [Abstract][Full Text] [Related]
8. Interactions of radiation and cancer chemotherapeutic drugs in a C3H mouse mammary carcinoma.
von der Maase H; Overgaard J
Acta Radiol Oncol; 1985; 24(2):181-7. PubMed ID: 2988283
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of murine MCa-4 carcinoma radioresponse by 9-amino-20(S)-camptothecin.
Kirichenko AV; Rich TA; Newman RA; Travis EL
Cancer Res; 1997 May; 57(10):1929-33. PubMed ID: 9157987
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxicities of mitomycin C and x rays to aerobic and hypoxic cells in vitro.
Rockwell S
Int J Radiat Oncol Biol Phys; 1982 Jun; 8(6):1035-9. PubMed ID: 6809713
[TBL] [Abstract][Full Text] [Related]
11. Interactions of radiation, cyclophosphamide and nimorazole in a C3H mammary carcinoma in vivo.
Zachariae C; Overgaard J
Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1445-8. PubMed ID: 3759571
[TBL] [Abstract][Full Text] [Related]
12. Experimental studies on interactions of radiation and cancer chemotherapeutic drugs in normal tissues and a solid tumour.
von der Maase H
Radiother Oncol; 1986 Sep; 7(1):47-68. PubMed ID: 2430317
[TBL] [Abstract][Full Text] [Related]
13. Effects of mitomycin C alone and in combination with X-rays on EMT6 mouse mammary tumors in vivo.
Rockwell S
J Natl Cancer Inst; 1983 Oct; 71(4):765-71. PubMed ID: 6413743
[TBL] [Abstract][Full Text] [Related]
14. Hyperbaric oxygen and radiobiology of a C3H mouse mammary carcinoma.
Suit HD; Maeda M
J Natl Cancer Inst; 1967 Oct; 39(4):639-52. PubMed ID: 18623926
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of photodynamic therapy by mitomycin C: a preclinical and clinical study.
Baas P; van Geel IP; Oppelaar H; Meyer M; Beynen JH; van Zandwijk N; Stewart FA
Br J Cancer; 1996 Apr; 73(8):945-51. PubMed ID: 8611430
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of mitomycin C-dextran conjugate against various murine tumors.
Hashida M; Kato A; Kojima T; Muranishi S; Sezaki H; Tanigawa N; Satomura K; Hikasa Y
Gan; 1981 Apr; 72(2):226-34. PubMed ID: 6169584
[TBL] [Abstract][Full Text] [Related]
17. The effects of three bioreductive drugs (mitomycin C, RSU-1069 and SR4233) on cell lines selected for their sensitivity to mitomycin C or ionising radiation.
Keohane A; Godden J; Stratford IJ; Adams GE
Br J Cancer; 1990 May; 61(5):722-6. PubMed ID: 2110815
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity and toxicity in animals of N-7[2-(4-nitrophenyldithio) ethyl] mitomycin C (BMY-25067).
Bradner WT; Rose WC; Schurig JE; Florczyk AP
Invest New Drugs; 1990; 8 Suppl 1():S1-7. PubMed ID: 2380013
[TBL] [Abstract][Full Text] [Related]
19. An antiangiogenic agent (TNP-470) inhibited reoxygenation during fractionated radiotherapy of murine mammary carcinoma.
Murata R; Nishimura Y; Hiraoka M
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1107-13. PubMed ID: 9169820
[TBL] [Abstract][Full Text] [Related]
20. Improved tumor response by combining radiation and the vascular-damaging drug 5,6-dimethylxanthenone-4-acetic acid.
Murata R; Siemann DW; Overgaard J; Horsman MR
Radiat Res; 2001 Nov; 156(5 Pt 1):503-9. PubMed ID: 11604063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
